Skip to main content
. 2021 Jun 3;18(4):1290–1298. doi: 10.1109/TCBB.2021.3085972

TABLE 2. Candidate Drugs Predicted by the Model Based on the Targets.

Target (Uniprot IDs) Candidate drugs (DrugBank IDs) Clinical study's NCT Number
Interleukin-1 beta (P01584) Minocycline (DB01017)
Arsenic trioxide (DB01169)
Thalidomide (DB01041) NCT04273529
Tetracycline (DB00759)
Indomethacin (DB00328) NCT04344457
ACE2 (Q9BYF1) Quinapril (DB00881)
Fosinopril (DB00492)
Cilazapril (DB01340)
Benazepril (DB00542)
Perindopril (DB00790)
Moexipril (DB00691)
Trandolapril (DB00519)
Atorvastatin (DB01076) NCT04380402
Tumor necrosis factor (P01375) Thalidomide (DB01041) NCT04273529
Chloroquine (DB00608)
Arsenic trioxide (DB01169)
Bortezomib (DB00188)
Zonisamide (DB00909)
Miconazole (DB01110)
Indomethacin (DB00328) NCT04344457
Gemcitabine (DB00441)
Acetazolamide (DB00819)
Minocycline (DB01017)